Liminatus Pharma Stock (LIMN)
Track Liminatus Pharma stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.
LIMN
Liminatus Pharma
healthcare
$0.17
▼ -4.89 (-96.45%) past year
Market Cap
$7.36M
P/E Ratio
—
1Y Return
-96.45%
EPS (TTM)
-$0.40
Read the latest TheStreet Pro articles mentioning Liminatus Pharma, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning LIMN yet.
Daily Diary Mentions
0 mentionsNo diary mentions for LIMN yet.